CD274 and neoplasm: Tumor PD-L1 expression substantially affects the efficacy of chemoimmunotherapy combinations in NSCLC [2,3]; therefore, we investigated the effect of C. butyricum therapy using CBM588 on OS, based on PD-L1 expression in 94 patients for whom PD-L1 expression was determined.